Stemtech Corporation (STEK)

Market Cap	297.27K
Revenue (ttm)	3.73M
Net Income (ttm)	-2.96M
Shares Out	495.44M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	372,341
Average Volume	14,336,342
Open	0.0006
Previous Close	0.0006
Day's Range	0.0005 - 0.0006
52-Week Range	0.0005 - 0.0498
Beta	2.26
RSI	32.48
Earnings Date	May 11, 2026

About Stemtech

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company’s products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 80
• Stock Exchange: OTCMKTS
• Ticker Symbol: STEK

Financial Performance

In 2024, Stemtech's revenue was $5.05 million, an increase of 2.69% compared to the previous year's $4.92 million. Losses were -$3.77 million, -30.58% less than in 2023.